Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Gustoeson Jan 16, 2015 9:08am

73 Views

Post# 23327039

RE:RE:RE:Common sense should prevail

vestor111 wrote: BTW The list of 2014 accomplishments is rather impressive unto itself - especially for investors or partners not fully aware of TLT. So I suspect the list will be a major part of the presentation (a duh) but a new finding, approval, paper or all of the above would be great for the show.

Bring on a wow, please.

nm. This answers my question. I wonder if we'll hear any news out of the conference. Will have to check twitter later to see if any comments by chance.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario